UBS Starts Allscripts (MDRX) at Buy

October 6, 2016 7:08 AM EDT
Get Alerts MDRX Hot Sheet
Price: $11.42 -0.26%

Rating Summary:
    13 Buy, 23 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade MDRX Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

UBS initiates coverage on Allscripts (NASDAQ: MDRX) with a Buy rating and a price target of $17.00.

Analyst Michael Cherny commented, "We are initiating coverage on Allscripts with a Buy rating and a $17 price target. MDRX remains in the midst of a multi-year turnaround, including repositioning the go-tomarket strategy as well as right-sizing the cost base. While the MDRX of today is far different to the company 3 years ago (early in Paul Black’s tenure), shares trade at roughly the same level, giving no credit for the strategic improvements the company has made."

For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.

Shares of Allscripts closed at $13.04 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities


Add Your Comment